(Q30394414)

English

Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

Nicola Principi

9

object named as

Nicola Principi

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Susanna Esposito

1

object named as

Susanna Esposito

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Emanuela D'Angelo

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Cristina Daleno

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Francesco Peia

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Alessia Scala

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Domenico Serra

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Nadia Mirra

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Carlotta Galeone

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

7825-7828

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Increased risk of sepsis after splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Immune response after splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Antibody response to influenza vaccination in splenectomized patients in Poland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Large trials confirm immunogenicity of H1N1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Summary of Clinical Trials of Influenza Virus Vaccines in Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.058

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.09.058

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30394414&oldid=1794335289"